Correction to: A phase II study of post‑transplant cyclophosphamide combined with tacrolimus for GVHD prophylaxis after HLA‑matched related/unrelated allogeneic hematopoietic stem cell transplantation

被引:0
|
作者
Hirohisa Nakamae
Takahiko Nakane
Hiroshi Okamura
Hideo Koh
Yasuhiro Nakashima
Asao Hirose
Mika Nakamae
Mitsutaka Nishimoto
Masatomo Kuno
Yosuke Makuuchi
Naonori Harada
Teruhito Takakuwa
Masayuki Hino
机构
[1] Osaka City University,Hematology, Graduate School of Medicine
来源
关键词
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:146 / 146
相关论文
共 50 条
  • [21] GVHD prophylaxis with post-transplant cyclophosphamide results in lower incidence of GVHD and allows faster immunosuppressive treatment reduction compared to antithymocyte globulin in 10/10 HLA-matched unrelated allogeneic hematopoietic cell transplantation
    François Dachy
    Sabine Furst
    Boris Calmels
    Thomas Pagliardini
    Samia Harbi
    Benjamin Bouchacourt
    Anne Calleja
    Claude Lemarie
    Aude Collignon
    Guillaume Morel
    Faezeh Legrand
    Elena Bekrieva
    Angela Granata
    Pierre Jean Weiller
    Christian Chabannon
    Jean Marc Schiano
    Norbert Vey
    Didier Blaise
    Raynier Devillier
    [J]. Bone Marrow Transplantation, 2023, 58 : 1179 - 1181
  • [22] Post-transplant high-dose cyclophosphamide (PTCy) is an effective GVHD prophylaxis after unrelated HLA-matched (8/8) and mismatched (7/8) peripheral blood allogeneic stem cell transplantation
    Martinez, C.
    Kwon, M.
    Pascual-Cascon, M. J.
    Rovira, M.
    Fernandez-Aviles, F.
    Gutierrez, G.
    Suarez-Lledo, M.
    Isola, I.
    Urbano-Ispizua, A.
    [J]. BONE MARROW TRANSPLANTATION, 2016, 51 : S172 - S173
  • [23] POST-TRANSPLANT CYCLOPHOSPHAMIDE VERSUS ANTITHYMOCYTE GLOBULIN AS GVHD PROPHYLAXIS IN PATIENTS UNDERGOING ALLOGENEIC STEM CELL TRANSPLANTATION FROM 10/10 HLA MATCHED UNRELATED DONORS - A SINGLE CENTER ANALYSIS
    Valkova, Veronika
    Vydra, Jan
    Markova, Marketa Stastna
    Novakova, Ludmila
    Cemusova, Barbora
    Koubova, Mariana
    Bartakova, Hana
    Kolar, Michal
    Cetkovsky, Petr
    Vitek, Antonin
    [J]. BONE MARROW TRANSPLANTATION, 2023, 58 (SUPP1) : 288 - 288
  • [24] Comparison of Tacrolimus and Post-Transplant Cyclophosphamide (PTCy) with Tacrolimus and Methotrexate (Tac/MTX) Gvhd Prophylaxis in Patients with AML Undergoing Transplantation from Matched Related or Unrelated Donors
    Popat, Uday R.
    Saliba, Rima M.
    Olson, Amanda
    Mehta, Rohtesh S.
    Ahmed, Sairah
    Alousi, Amin M.
    Anderlini, Paolo
    Al-Atrash, Gheath
    Bashir, Qaiser
    Ciurea, Stefan O.
    Hosing, Chitra M.
    Im, Jin Seon
    Kebriaei, Partow
    Khouri, Issa F.
    Marin, David
    Molldrem, Jeffrey J.
    Nieto, Yago
    Oran, Betul
    Qazilbash, Muzaffar H.
    Rezvani, Katy
    Rondon, Gabriela
    Shpall, E. J. J.
    Varma, Ankur
    Andersson, Borje S.
    Champlin, Richard E.
    [J]. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2019, 25 (03)
  • [25] The Outcome of the Combination of Tacrolimus, Sirolimus, and ATG for GvHD Prophylaxis on Allogeneic Stem Cell Transplantation From Matched Unrelated Donors.
    Homsi, Yaser
    Alwan, Dareen
    Kiel, Patrick
    Rosenbeck, Lindsay
    Shivani, Srivastava
    Schwartz, Jennifer E.
    Nelson, Robert P., Jr.
    Abonour, Rafat
    Robertson, Michael
    Farag, Sherif
    [J]. BLOOD, 2010, 116 (21) : 969 - 969
  • [26] Hemorrhagic Cystitis in Patients Undergoing Allogeneic Hematopoietic Cell Transplant with Post Transplant Cyclophosphamide As GvHD Prophylaxis
    Ngo, Dat
    Mac, Stephanie
    Yang, Dongyun
    Mokhtari, Saloomeh
    Chen, Jason
    Ali, Haris
    Arslan, Shukaib
    Salhotra, Amandeep
    Thai Cao
    Karras, Nicole
    Aldoss, Ibrahim
    Koller, Pkoller
    Artz, Andrew S.
    Aribi, Ahmed
    Sandhu, Karamjeet S.
    Karanes, Chatchada
    Khaled, Samer
    Pullarkat, Vinod A.
    Stein, Anthony S.
    Marcucci, Guido
    Smith, Eileen P.
    Forman, Stephen J.
    [J]. BLOOD, 2020, 136
  • [27] Post-Transplant Cyclophosphamide for Gvhd Prophylaxis in Matched Unrelated Donor Transplantation Compared to ATG-Based Prophylaxis
    Bailen, Rebeca
    Kwon, Mi
    Jesus Pascual-Cascon, Maria
    Torrent, Anna
    Ferra, Christelle M.
    Sanz, Jaime
    Doblas-Marquez, Alberto
    Benitez, Olga
    Pinana Sanchez, Jose Luis
    Oarbeascoa, Gillen
    Dorado, Nieves
    Cristina, Munoz
    Martinez-Laperche, Carolina
    Anguita, Javier
    Buno, Ismael
    Luis Diez-Martin, Jose
    [J]. BLOOD, 2019, 134
  • [28] Tacrolimus plus sirolimus with or without ATG as GVHD prophylaxis in HLA-mismatched unrelated donor allogeneic stem cell transplantation
    Kharfan-Dabaja, M. A.
    Parody, R.
    Perkins, J.
    Lopez-Godino, O.
    Lopez-Corral, L.
    Vazquez, L.
    Caballero, D.
    Falantes, J.
    Shapiro, J.
    Orti, G.
    Barba, P.
    Valcarcel, D.
    Esquirol, A.
    Martino, R.
    Pinana, J. L.
    Solano, C.
    Tsalatsanis, A.
    Pidala, J.
    Anasetti, C.
    Perez-Simon, J. A.
    [J]. BONE MARROW TRANSPLANTATION, 2017, 52 (03) : 438 - 444
  • [29] Effect of HLA mismatch on post-transplant infections in allogeneic hematopoietic stem cell transplantation with PTCy-based GvHD prophylaxis
    Marra, J. D.
    Galli, E.
    Giammarco, S.
    Chiusolo, P.
    Metafuni, E.
    Sora, F.
    Laurenti, L.
    Innocenti, I.
    Autore, F.
    Limongiello, M. A.
    Fresa, A.
    Bacigalupo, A.
    Sica, S.
    [J]. BONE MARROW TRANSPLANTATION, 2023, 58 (09) : 1042 - 1044
  • [30] Allogeneic stem cell transplantation at-home program in the post-transplant cyclophosphamide GVHD prophylaxis era
    Gutierrez-Garcia, Gonzalo
    Rovira, Montserrat
    Ayora, Pilar
    Domenech, Ariadna
    Gallego, Cristina
    Teresa Solano, Maria
    Moreno-Castano, Ana B.
    Suarez-Lledo, Maria
    Borras, Nuria
    Gerardo Rodriguez-Lobato, Luis
    Cesar Solano-Vega, Julio
    Rosinol, Laura
    Martinez, Carmen
    Marin, Pedro
    Adelina Hernando, Maria
    Urbano-Ispizua, Alvaro
    Fernandez-Aviles, Francesc
    [J]. BONE MARROW TRANSPLANTATION, 2019, 54 : 234 - 234